000 | 01889 a2200469 4500 | ||
---|---|---|---|
005 | 20250518083012.0 | ||
264 | 0 | _c20201020 | |
008 | 202010s 0 0 eng d | ||
022 | _a1083-351X | ||
024 | 7 |
_a10.1074/jbc.RA119.011930 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Hua | |
245 | 0 | 0 |
_aThe GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells. _h[electronic resource] |
260 |
_bThe Journal of biological chemistry _c03 2020 |
||
300 |
_a3055-3063 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAmino Acid Transport System y+ _xmetabolism |
650 | 0 | 4 |
_aAntioxidants _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 |
_aGlutathione Disulfide _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xmetabolism |
650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xantagonists & inhibitors |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aral GTP-Binding Proteins _xantagonists & inhibitors |
700 | 1 | _aXiang, Shengyan | |
700 | 1 | _aKazi, Aslamuzzaman | |
700 | 1 | _aSebti, Said M | |
773 | 0 |
_tThe Journal of biological chemistry _gvol. 295 _gno. 10 _gp. 3055-3063 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1074/jbc.RA119.011930 _zAvailable from publisher's website |
999 |
_c30579695 _d30579695 |